Skip to main content

Table 5 Basic information of HCV patients in hypoxia-immune-based risk models

From: Exploration of a hypoxia-immune-related microenvironment gene signature and prediction model for hepatitis C-induced early-stage fibrosis

Characteristics

Whole cohort (216)

Hypoxia low Immune low (162)

Hypoxia high Immune high (54)

Survival

150(69.44%)

123(75.93%)

27(50.00%)

Survival time (days)

3373.13 ± 1525.10

3498.77 ± 1475.46

2996.22 ± 1621.51

Bilirubin ≥ 1.0 mg/dl

108(50.00%)

79(48.77%)

29(53.70%)

HCC

65(30.09%)

45(27.78%)

20(37.04%)

  1. TB Total Bilirubin, DB Direct Bilirubin, IB Indirect Bilirubin, ALT Alanine aminotransferase, AST Aspartate aminotransferase, HCC Hepatic carcinoma, HCV hepatitis C virus
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us